Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cenobamate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cenobamate 200mg tablets
0408010ANAAADAD
|
Cenobamate | Cenobamate | Central Nervous System | 5,257 |
|
Cenobamate 50mg tablets
0408010ANAAAAAA
|
Cenobamate | Cenobamate | Central Nervous System | 3,100 |
|
Cenobamate 100mg tablets
0408010ANAAABAB
|
Cenobamate | Cenobamate | Central Nervous System | 3,059 |
|
Cenobamate 150mg tablets
0408010ANAAACAC
|
Cenobamate | Cenobamate | Central Nervous System | 1,635 |
|
Cenobamate 12.5mg tablets and Cenobamate 25mg tablets
0408010ANAAAEAE
|
Cenobamate | Cenobamate | Central Nervous System | 310 |
|
Ontozry 200mg tablets
0408010ANBBADAD
|
Ontozry | Cenobamate | Central Nervous System | 70 |
|
Ontozry 50mg tablets
0408010ANBBAAAA
|
Ontozry | Cenobamate | Central Nervous System | 40 |
|
Ontozry 100mg tablets
0408010ANBBABAB
|
Ontozry | Cenobamate | Central Nervous System | 36 |
|
Ontozry 150mg tablets
0408010ANBBACAC
|
Ontozry | Cenobamate | Central Nervous System | 10 |
|
Ontozry 12.5mg/25mg tablets treatment initiation pack
0408010ANBBAEAE
|
Ontozry | Cenobamate | Central Nervous System | 5 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.